doctors are worried about prescribing glp 1 GLP-1s: Evidence, limits, expectations Why I Prescribe GLP-1 Agonists
Description
What Clinical Trials Reveal About Tirzepatide and Mood The SURMOUNT-4 trial and other major studies tracking tirzepatide found that depression and anxiety each occurred in fewer than 2% of participants at treatment-ending doses
Potential protective effects may arise from multiple mechanisms, including the complex interplay between weight stigmatization, psychological distress, and improvements in overall health and self-perception among adolescents ( 15 , 16 )
Most brand-name GLP-1s are very expensive without coverage
In our 20+ years in the field, weve seen too many great devices undone by bad packaging
doi: 10.2337/diab.28.12.1141 [DOI] [PubMed] [Google Scholar] 172
Real-world evidence further strengthens the neuroprotective potential of GLP-1 RAs
